![Emmanuel Hanon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Emmanuel Hanon currently works at Vicebio Ltd., as Chief Executive Officer from 2022 and Viome Life Sciences, Inc., as Global Head-Research & Development.
Postes actifs de Emmanuel Hanon
| Sociétés | Poste | Début |
|---|---|---|
Viome Life Sciences, Inc.
 Viome Life Sciences, Inc. Packaged SoftwareTechnology Services Develops AI methods to discover host/microbial biomarkers that predict the risk of developing severe chronic conditions, including cancers and sells testing devices through online | Corporate Officer/Principal | - |
Vicebio Ltd.
 Vicebio Ltd. BiotechnologyHealth Technology Develops next-generation respiratory virus vaccines using molecular clamp technology | Directeur Général | 01/05/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Viome Life Sciences, Inc.
Viome Life Sciences, Inc. Packaged SoftwareTechnology Services Develops AI methods to discover host/microbial biomarkers that predict the risk of developing severe chronic conditions, including cancers and sells testing devices through online | Technology Services |
Vicebio Ltd.
Vicebio Ltd. BiotechnologyHealth Technology Develops next-generation respiratory virus vaccines using molecular clamp technology | Health Technology |
